• Je něco špatně v tomto záznamu ?

Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment

C. Pappas, BJ. Small, R. Andel, J. Laczó, M. Parizkova, L. Ondrej, J. Hort,

. 2019 ; 67 (1) : 81-89. [pub] -

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc20006720

BACKGROUND: Identifying protective factors that promote healthy cognitive aging is of importance due to the growing older adult population. Preventing chronic hyperglycemia may be one such way to preserve cognitive abilities, as high blood glucose levels have been associated with cognitive impairment and decline. OBJECTIVE: To evaluate the influence of blood glucose levels on cognition among older adults using common neuropsychological tests and a spatial navigation task. METHODS: The association between cognitive performance and blood glucose levels was assessed among 117 older adults classified as cognitively healthy, subjective cognitive decline, amnestic mild cognitive impairment, or Alzheimer's disease dementia from the Czech Brain Aging Study. Cognitive abilities were measured by tests of verbal memory, nonverbal memory, working memory, visuospatial skills, and executive function. A test of spatial navigation known as the Hidden Goal Task was also used. Blood glucose levels were measured by glycosylated hemoglobin A1c (HbA1c). Analyses were performed using multiple linear regression controlling for age, gender, education, depressive symptoms, diabetes, and cognitive status. RESULTS: A significant relationship was observed for HbA1c and executive function performance (beta = -2.46, SE = 0.92, p = 0.008). Following moderation analysis, this relationship was significant only among those with cognitive impairment (beta = -4.37, SE = 1.28, p = 0.001, 95% CI [-6.91, -1.83]). Associations between HbA1c and other cognitive domains were not significant (ps > 0.05). CONCLUSIONS: Higher HbA1c was associated with poorer executive function among persons with cognitive impairment, but not with performance on other cognitive domains. Maintaining proper glucoregulation may help preserve executive function performance among cognitively impaired older adults.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20006720
003      
CZ-PrNML
005      
20200527092741.0
007      
ta
008      
200511s2019 ne f 000 0|eng||
009      
AR
024    7_
$a 10.3233/JAD-180693 $2 doi
035    __
$a (PubMed)30475768
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Pappas, Colleen $u Department of Food Science and Human Nutrition, Iowa State University, Ames, IA, USA.
245    10
$a Blood Glucose Levels May Exacerbate Executive Function Deficits in Older Adults with Cognitive Impairment / $c C. Pappas, BJ. Small, R. Andel, J. Laczó, M. Parizkova, L. Ondrej, J. Hort,
520    9_
$a BACKGROUND: Identifying protective factors that promote healthy cognitive aging is of importance due to the growing older adult population. Preventing chronic hyperglycemia may be one such way to preserve cognitive abilities, as high blood glucose levels have been associated with cognitive impairment and decline. OBJECTIVE: To evaluate the influence of blood glucose levels on cognition among older adults using common neuropsychological tests and a spatial navigation task. METHODS: The association between cognitive performance and blood glucose levels was assessed among 117 older adults classified as cognitively healthy, subjective cognitive decline, amnestic mild cognitive impairment, or Alzheimer's disease dementia from the Czech Brain Aging Study. Cognitive abilities were measured by tests of verbal memory, nonverbal memory, working memory, visuospatial skills, and executive function. A test of spatial navigation known as the Hidden Goal Task was also used. Blood glucose levels were measured by glycosylated hemoglobin A1c (HbA1c). Analyses were performed using multiple linear regression controlling for age, gender, education, depressive symptoms, diabetes, and cognitive status. RESULTS: A significant relationship was observed for HbA1c and executive function performance (beta = -2.46, SE = 0.92, p = 0.008). Following moderation analysis, this relationship was significant only among those with cognitive impairment (beta = -4.37, SE = 1.28, p = 0.001, 95% CI [-6.91, -1.83]). Associations between HbA1c and other cognitive domains were not significant (ps > 0.05). CONCLUSIONS: Higher HbA1c was associated with poorer executive function among persons with cognitive impairment, but not with performance on other cognitive domains. Maintaining proper glucoregulation may help preserve executive function performance among cognitively impaired older adults.
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a Alzheimerova nemoc $x krev $x psychologie $7 D000544
650    _2
$a krevní glukóza $x analýza $7 D001786
650    _2
$a kognitivní dysfunkce $x krev $x psychologie $7 D060825
650    12
$a exekutivní funkce $7 D056344
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a glykovaný hemoglobin $x analýza $7 D006442
650    _2
$a zdravé stárnutí $7 D000073656
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a paměť $7 D008568
650    _2
$a krátkodobá paměť $7 D008570
650    _2
$a neuropsychologické testy $7 D009483
650    _2
$a vnímání prostoru $7 D013028
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Small, Brent J $u School of Aging Studies, University of South Florida, Tampa, FL, USA.
700    1_
$a Andel, Ross $u School of Aging Studies, University of South Florida, Tampa, FL, USA. International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic.
700    1_
$a Laczó, Jan $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Neurology, Memory Clinic, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Parizkova, Martina $u Department of Neurology, Memory Clinic, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Ondrej, Lerch $u Department of Neurology, Memory Clinic, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
700    1_
$a Hort, Jakub $u International Clinical Research Center, St. Anne's University Hospital Brno, Brno, Czech Republic. Department of Neurology, Memory Clinic, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic.
773    0_
$w MED00006350 $t Journal of Alzheimer's disease : JAD $x 1875-8908 $g Roč. 67, č. 1 (2019), s. 81-89
856    41
$u https://pubmed.ncbi.nlm.nih.gov/30475768 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20200511 $b ABA008
991    __
$a 20200527092738 $b ABA008
999    __
$a ok $b bmc $g 1525578 $s 1096776
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 67 $c 1 $d 81-89 $e - $i 1875-8908 $m Journal of Alzheimer's disease $n J Alzheimers Dis $x MED00006350
LZP    __
$a Pubmed-20200511

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace